Evaluation of HLA class I and HLA class II allele profile and its relationship with clinical features in patients with alopecia areata: a case-control study

被引:5
作者
Hayran, Yildiz [1 ]
Korkut, Melek Gunindi [2 ]
Oktem, Ayse [3 ]
Sen, Orhan [1 ]
Aksoy, Gunes Gur [1 ]
Ozmen, Fusun [2 ]
机构
[1] Ankara City Hosp, Dept Dermatol, Bilkent Blv 1, TR-06800 Ankara, Turkey
[2] Hacettepe Univ, Dept Basic Oncol, Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Dermatol, Ankara, Turkey
关键词
Alopecia areata; HLA; disease characteristics; prognostic factors; T-CELLS; ASSOCIATION; HAIR; DISEASE; PREVALENCE; GUIDELINES; HAPLOTYPE; HLA-DQA1; VACCINE; MODEL;
D O I
10.1080/09546634.2021.1937478
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Alopecia areata (AA) is an autoimmune disease where autoimmune dysregulations along with genetic susceptibility are hypothesized to play a role in pathogenesis. Objective The aim of this study in to evaluate HLA-A, HLA-B, HLA-C, HLA-DQB1, and HLA-DRB1 profile and its relationship with clinical features in AA patients. Materials and methods Ninety-eight patients with AA and 100 healthy controls were included in the study. HLA-A, HLA-B, HLA-C, HLA-DQB1, and HLA-DRB1 frequencies were analyzed using polymerase chain reaction-sequence specific primers (PCR-SSP). Results HLA-B*39 and HLA-HLA-DRB1*15 allele frequencies were increased (p = .022 and p = .023, respectively), HLA-A*11 and HLA-B*35 frequencies were decreased (p = .006 and p = .014, respectively) in AA patients. HLA-B*13 and HLA-DRB1*11 were associated with poor prognostic factors. A class I allele, HLA-B*13 was associated with recurrence (p = .023) and presence of nevus flammeus (p = .022), while the class II allele HLA-DRB1*11 was associated with widespread hair loss (diffuse or universal alopecia) (p = .026), presence of ophiasis (p = .049) and juvenile onset (p = .018). Conclusion Belonging to two different classes of HLA family, HLA-B*13 and HLA-DRB1*11 alleles identified separate set of risk factors. In addition to increasing the risk of AA, HLA alleles may affect the prognosis of the disease.
引用
收藏
页码:2175 / 2181
页数:7
相关论文
共 55 条
  • [1] Akar A, 2002, EUR J DERMATOL, V12, P236
  • [2] Association between alopecia areata and HLA class I and II in Turkey
    Aliagaoglu, C
    Pirim, I
    Atasoy, M
    Egerci, N
    Aktas, A
    [J]. JOURNAL OF DERMATOLOGY, 2005, 32 (09) : 711 - 714
  • [3] HLA-DQA1 AND HLA-DQB1 ALLELE AND GENOTYPE CONTRIBUTION TO IDDM SUSCEPTIBILITY IN AN ETHNICALLY MIXED POPULATION
    BALDUCCISILANO, PL
    LAYRISSE, Z
    DOMINGUEZ, E
    AMARO, R
    GUNCZLER, P
    LANES, R
    ZARO, R
    [J]. EUROPEAN JOURNAL OF IMMUNOGENETICS, 1994, 21 (06): : 405 - 414
  • [4] Behrangi Elham, 2017, Middle East J Dig Dis, V9, P107, DOI 10.15171/mejdd.2017.59
  • [5] A meta-analysis of association of Human Leukocyte Antigens A, B, C, DR and DQ with Human Papillomavirus 16 infection
    Bhaskaran, Muthumeenakshi
    ArunKumar, GaneshPrasad
    [J]. INFECTION GENETICS AND EVOLUTION, 2019, 68 : 194 - 202
  • [6] Familial aggregation of alopecia areata
    Blaumeiser, B
    van der Groot, I
    Fimmers, R
    Hanneken, S
    Ritzmann, S
    Seymons, K
    Betz, RC
    Ruzicka, T
    Wienker, TF
    De Weert, J
    Lambert, J
    Kruse, R
    Nöthen, MM
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) : 627 - 632
  • [7] Alopecia Areata of the Beard: A Review of the Literature
    Cervantes, Jessica
    Fertig, Raymond M.
    Maddy, Austin
    Tosti, Antonella
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (06) : 789 - 796
  • [8] ALOPECIA UNIVERSALIS IN IDENTICAL-TWINS
    COLE, GW
    HERZLINGER, D
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1984, 23 (04) : 283 - 283
  • [9] Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients
    Da Costa, C. Marques
    Dupont, E.
    Van der Cruys, M.
    Andrien, M.
    Hidajat, M.
    Song, M.
    Stene, J. J.
    [J]. DERMATOLOGY, 2006, 213 (01) : 12 - 14
  • [10] A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
    Geier, David A.
    Geier, Mark R.
    [J]. CLINICAL RHEUMATOLOGY, 2015, 34 (07) : 1225 - 1231